Literature DB >> 31478652

Functional Annotation of ABHD14B, an Orphan Serine Hydrolase Enzyme.

Abinaya Rajendran1, Kaveri Vaidya1, Johnny Mendoza2, Jennifer Bridwell-Rabb2, Siddhesh S Kamat1.   

Abstract

The metabolic serine hydrolase family is, arguably, one of the largest functional enzyme classes in mammals, including humans, comprising 1-2% of the total proteome. This enzyme family uses a conserved nucleophilic serine residue in the active site to perform diverse hydrolytic reactions and consists of proteases, lipases, esterases, amidases, and transacylases, which are prototypical members of this family. In humans, this enzyme family consists of >250, of which approximately 40% members remain unannotated, in terms of both their endogenous substrates and the biological pathways that they regulate. The enzyme ABHD14B, an outlying member of this family, is also known as CCG1/TAFII250-interacting factor B, as it was found to be associated with transcription initiation factor TFIID. The crystal structure of human ABHD14B was determined more than a decade ago; however, its endogenous substrates remain elusive. In this paper, we annotate ABHD14B as a lysine deacetylase (KDAC), showing this enzyme's ability to transfer an acetyl group from a post-translationally acetylated lysine to coenzyme A (CoA), to yield acetyl-CoA, while regenerating the free amine of protein lysine residues. We validate these findings by in vitro biochemical assays using recombinantly purified human ABHD14B in conjunction with cellular studies in a mammalian cell line by knocking down ABHD14B and by identification of a putative substrate binding site. Finally, we report the development and characterization of a much-needed, exquisitely selective ABHD14B antibody, and using it, we map the cellular and tissue distribution of ABHD14B and prospective metabolic pathways that this enzyme might biologically regulate.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31478652      PMCID: PMC6976303          DOI: 10.1021/acs.biochem.9b00703

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  80 in total

1.  Ubiquitin-activating/conjugating activity of TAFII250, a mediator of activation of gene expression in Drosophila.

Authors:  A D Pham; F Sauer
Journal:  Science       Date:  2000-09-29       Impact factor: 47.728

2.  A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases.

Authors:  Weiwei Li; Jacqueline L Blankman; Benjamin F Cravatt
Journal:  J Am Chem Soc       Date:  2007-07-13       Impact factor: 15.419

3.  Introducing the acetylome.

Authors:  Karen T Smith; Jerry L Workman
Journal:  Nat Biotechnol       Date:  2009-10       Impact factor: 54.908

Review 4.  The metabolic serine hydrolases and their functions in mammalian physiology and disease.

Authors:  Jonathan Z Long; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2011-06-23       Impact factor: 60.622

Review 5.  The world of protein acetylation.

Authors:  Adrian Drazic; Line M Myklebust; Rasmus Ree; Thomas Arnesen
Journal:  Biochim Biophys Acta       Date:  2016-06-11

6.  Localization of sporadic neuroendocrine tumors by gene expression analysis of their metastases.

Authors:  Nicole Posorski; Daniel Kaemmerer; Guenther Ernst; Patricia Grabowski; Dieter Hoersch; Merten Hommann; Ferdinand von Eggeling
Journal:  Clin Exp Metastasis       Date:  2011-06-17       Impact factor: 5.150

7.  Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors.

Authors:  James E Korkola; Jane Houldsworth; Rajendrakumar S V Chadalavada; Adam B Olshen; Debbie Dobrzynski; Victor E Reuter; George J Bosl; R S K Chaganti
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

Review 8.  Histone modifying enzymes: structures, mechanisms, and specificities.

Authors:  Ronen Marmorstein; Raymond C Trievel
Journal:  Biochim Biophys Acta       Date:  2008-08-03

9.  NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung cancer.

Authors:  Akhileshwar Namani; Qin Qin Cui; Yihe Wu; Hongyan Wang; Xiu Jun Wang; Xiuwen Tang
Journal:  Oncotarget       Date:  2017-07-18

10.  A chemical-genetic screen identifies ABHD12 as an oxidized-phosphatidylserine lipase.

Authors:  Dhanashree S Kelkar; Govindan Ravikumar; Neelay Mehendale; Shubham Singh; Alaumy Joshi; Ajay Kumar Sharma; Amol Mhetre; Abinaya Rajendran; Harinath Chakrapani; Siddhesh S Kamat
Journal:  Nat Chem Biol       Date:  2019-01-14       Impact factor: 15.040

View more
  5 in total

1.  A Superfamily-wide Activity Atlas of Serine Hydrolases in Drosophila melanogaster.

Authors:  Kundan Kumar; Amol Mhetre; Girish S Ratnaparkhi; Siddhesh S Kamat
Journal:  Biochemistry       Date:  2021-04-07       Impact factor: 3.162

2.  Fatty acid chain length drives lysophosphatidylserine-dependent immunological outputs.

Authors:  Neha Khandelwal; Minhaj Shaikh; Amol Mhetre; Shubham Singh; Theja Sajeevan; Alaumy Joshi; Kithiganahalli Narayanaswamy Balaji; Harinath Chakrapani; Siddhesh S Kamat
Journal:  Cell Chem Biol       Date:  2021-02-10       Impact factor: 8.116

3.  Mapping the Neuroanatomy of ABHD16A, ABHD12, and Lysophosphatidylserines Provides New Insights into the Pathophysiology of the Human Neurological Disorder PHARC.

Authors:  Shubham Singh; Alaumy Joshi; Siddhesh S Kamat
Journal:  Biochemistry       Date:  2020-06-03       Impact factor: 3.162

4.  Activity-based protein profiling guided identification of urine proteinase 3 activity in subclinical rejection after renal transplantation.

Authors:  Mario Navarrete; Brice Korkmaz; Carla Guarino; Adam Lesner; Ying Lao; Julie Ho; Peter Nickerson; John A Wilkins
Journal:  Clin Proteomics       Date:  2020-06-16       Impact factor: 3.988

5.  The loss of enzymatic activity of the PHARC-associated lipase ABHD12 results in increased phagocytosis that causes neuroinflammation.

Authors:  Shubham Singh; Siddhesh S Kamat
Journal:  Eur J Neurosci       Date:  2021-11-11       Impact factor: 3.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.